RecruitingNot ApplicableNCT05744336

Impact of Virtual Reality on Anxiety in Patients Undergoing Interventional Procedures

Assessing the Impact of Immersive Virtual Reality Experience on Injection-related Anxiety in Patients Undergoing Interventional Pain Spine Procedures: a Prospective Randomized Trial


Sponsor

Northwestern University

Enrollment

64 participants

Start Date

Mar 12, 2023

Study Type

INTERVENTIONAL

Conditions

Summary

Periprocedural anxiety is a common problem for patients who undergo interventional pain procedures. Virtual Reality (VR) is an immersive experience that has gained acceptance in the medical field as a tool for reducing anxiety and pain for patients.Research Aim: To evaluate the effect of immersive virtual reality (VR) on periprocedural anxiety related to therapeutic cervical epidural steroid injections (ESI). The investigators hypothesize that immersive virtual reality will result in a clinically meaningful anxiety reduction, defined as the proportion of participants with \> 50% reduction in Numeric Rating Scale (NRS) anxiety scores when compared to participants in the non-treatment group who will have standard preprocedural waiting time conditions in clinic, but no VR experience. Similarly, the investigators hypothesize a significant reduction in objective sympathetic tone as measured by skin sympathetic nerve activity (SKNA).


Eligibility

Min Age: 18 YearsMax Age: 80 Years

Inclusion Criteria5

  • Age 18-80 years old at day of enrollment
  • Neck pain patient deemed to be a candidate for pain control treatment with interventional fluoroscopically guided cervical epidural steroid injection as determined by their pain medicine provider based on history, physical exam, and radiographic findings
  • Willingness to undergo pre-procedural intervention of VR viewing experience or equivalent pre-procedural wait time
  • No history of prior epidural steroid injections
  • Did not receive sedatives prior to or during procedure

Exclusion Criteria9

  • Refusal / inability to participate or provide consent
  • Contraindications to injection (anticoagulated states, allergy to components of injection, local infection at injection site, current infectious process or treatment of antibiotics for current infection)
  • Uncontrolled anxiety disorder or untreated/inadequately treated psychiatric disorder
  • History of Alzheimer's, dementia, or cognitive dysfunction
  • Patient currently taking benzodiazepines
  • Severe motion sickness
  • Seizure disorder
  • Vision loss
  • Non-English speaking patients

Interventions

OTHERGroup 1 Immersive Virtual Reality (VR)

Participants in Group 1 Immersive Virtual Reality (VR) participants wear the device covering their eyes. The viewing experience will include calming nature sounds for between 15-20 minutes before their planned plain clinic procedure

OTHERGroup 2 Control Group

Group 2 control group participants have no preprocedural intervention. Standard clinic waiting conditions for 15-20 minutes before their planned pain clinic procedure.


Locations(1)

Anesthesiology Pain Medicine Center

Chicago, Illinois, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05744336


Related Trials